Literature DB >> 23710632

Incidence and management of anastomotic bleeding after ileocolic anastomosis.

T Golda1, C Zerpa, E Kreisler, L Trenti, S Biondo.   

Abstract

AIM: Ileocolic anastomosis is performed using a stapled or manual technique, but with either there is a risk of bleeding from the suture line. The aim of this study was to analyse, retrospectively, bleeding after different anastomotic techniques.
METHOD: Patients having elective right colectomy were divided, according to the type of ileocolic anastomosis, into Group 1 (circular, double-stapled, end-to-side), Group 2 (linear-stapled, side-to-side) and Group 3 (handsewn, side-to-side). Postoperative lower gastrointestinal bleeding (LGIB) was studied in the three groups. Uni- and multivariate analysis was performed to study risk factors for LGIB and the need for postoperative allogeneic blood transfusion.
RESULTS: Three-hundred and fifty patients were included: 174 in Group 1, 59 in Group 2 and 117 in Group 3. The postoperative LGIB rate was 4.9% and occurred exclusively in Group 1. Five patients had severe anastomotic bleeding. Postoperative blood transfusion was indicated in Groups 1, 2 and 3 in 19.0%, 5.1% and 13.7% of patients. In the five patients with severe bleeding, four attempts of colonoscopic arrest were made, achieving bleeding control in one. Angiographic embolization was successful in one patient. There were no procedure-specific complications.
CONCLUSION: End-to-side, circular, double-stapling ileocolic anastomosis seems to be related to an increased incidence of anastomotic bleeding and of postoperative blood transfusion compared with patients having other techniques of ileocolic anastomosis. Colorectal Disease
© 2013 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Keywords:  Right colectomy; anastomotic complication; gastrointestinal bleeding

Mesh:

Substances:

Year:  2013        PMID: 23710632     DOI: 10.1111/codi.12309

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  7 in total

1.  Risk of post-procedural bleeding in children on intravenous fish oil.

Authors:  Prathima Nandivada; Lorenzo Anez-Bustillos; Alison A O'Loughlin; Paul D Mitchell; Meredith A Baker; Duy T Dao; Gillian L Fell; Alexis K Potemkin; Kathleen M Gura; Ellis J Neufeld; Mark Puder
Journal:  Am J Surg       Date:  2016-12-01       Impact factor: 2.565

2.  Hemospray treatment for bleeding intestinal anastomoses in the early postoperative period: a novel non-operative approach.

Authors:  C Gubler; J M Metzler; M Turina
Journal:  Tech Coloproctol       Date:  2016-05-12       Impact factor: 3.781

Review 3.  Lower GI Bleeding: An Update on Incidences and Causes.

Authors:  Titilayo Adegboyega; David Rivadeneira
Journal:  Clin Colon Rectal Surg       Date:  2019-11-11

4.  Postoperative bleeding risk prediction for patients undergoing colorectal surgery.

Authors:  David Chen; Naveed Afzal; Sunghwan Sohn; Elizabeth B Habermann; James M Naessens; David W Larson; Hongfang Liu
Journal:  Surgery       Date:  2018-07-20       Impact factor: 3.982

5.  The Association of Coloproctology of Great Britain and Ireland consensus guidelines in emergency colorectal surgery.

Authors:  Andrew S Miller; Kathryn Boyce; Benjamin Box; Matthew D Clarke; Sarah E Duff; Niamh M Foley; Richard J Guy; Lisa H Massey; George Ramsay; Dominic A J Slade; James A Stephenson; Phil J Tozer; Danette Wright
Journal:  Colorectal Dis       Date:  2021-02       Impact factor: 3.917

6.  Tissue fusion technology versus suture and staple in porcine bowel anastomosis: an in vivo study.

Authors:  Hong Pan; Kevin K C Leung; Enders Kwok Wai Ng
Journal:  Braz J Med Biol Res       Date:  2020-04-17       Impact factor: 2.590

7.  Side-to-side versus end-to-side ileocolic anastomosis in right-sided colectomies: A cohort control study.

Authors:  Snow Yunni Lin; Bryan Jun Liang Buan; Wilson Sim; Sneha Rajiv Jain; Heidi Sian Ying Chang; Kuok Chung Lee; Choon Seng Chong
Journal:  J Minim Access Surg       Date:  2022 Jul-Sep       Impact factor: 1.018

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.